Pfizer Inc. (PFE) Q2 2017 Earnings Results

Pfizer Beats on EPS, Stock Down 0.24%

Pfizer's earnings report showed a slight beat on EPS, which indicates some operational success. However, the stock reacted negatively, declining by 0.24%. This could suggest that investors were looking for more comprehensive guidance or stronger revenue figures, which were not disclosed in this report.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.67	N/A	+1.52%

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting their commitment to core business operations. However, they did not provide specific guidance for future quarters.

We are pleased with our EPS performance this quarter.

We continue to focus on our core business areas.

Pfizer Beats on EPS, Stock Down 0.24%

Key numbers

Management commentary

Pfizer Inc.

More earnings this week

Pfizer Beats on EPS, Stock Down 0.24%

Key numbers

Management commentary